GO:0005956 | protein kinase CK2 complex | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0048820 | hair follicle maturation | 1.23e-03 | 1.00e+00 | 9.668 | 1 | 1 | 2 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0033683 | nucleotide-excision repair, DNA incision | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0032289 | central nervous system myelin formation | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0019887 | protein kinase regulator activity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 2 | 3 |
GO:0043139 | 5'-3' DNA helicase activity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0061154 | endothelial tube morphogenesis | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0035315 | hair cell differentiation | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0033211 | adiponectin-activated signaling pathway | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0071817 | MMXD complex | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 2 | 4 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0040016 | embryonic cleavage | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0032927 | positive regulation of activin receptor signaling pathway | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0000439 | core TFIIH complex | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0051101 | regulation of DNA binding | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 2 | 6 |
GO:0007165 | signal transduction | 4.37e-03 | 1.00e+00 | 2.982 | 3 | 24 | 618 |
GO:0005675 | holo TFIIH complex | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0009650 | UV protection | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 4 | 8 |
GO:0043249 | erythrocyte maturation | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0060218 | hematopoietic stem cell differentiation | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0071354 | cellular response to interleukin-6 | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0005095 | GTPase inhibitor activity | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0005737 | cytoplasm | 6.61e-03 | 1.00e+00 | 1.628 | 5 | 127 | 2633 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 4 | 11 |
GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0045859 | regulation of protein kinase activity | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 14 |
GO:0016575 | histone deacetylation | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 2 | 14 |
GO:0043623 | cellular protein complex assembly | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 14 |
GO:0000188 | inactivation of MAPK activity | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 15 |
GO:0021510 | spinal cord development | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 17 |
GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 17 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 17 |
GO:0031519 | PcG protein complex | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 3 | 18 |
GO:0008285 | negative regulation of cell proliferation | 1.12e-02 | 1.00e+00 | 3.555 | 2 | 11 | 277 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 3 | 20 |
GO:0071897 | DNA biosynthetic process | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 20 |
GO:0006363 | termination of RNA polymerase I transcription | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 3 | 21 |
GO:0043388 | positive regulation of DNA binding | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 21 |
GO:0030282 | bone mineralization | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 21 |
GO:0051539 | 4 iron, 4 sulfur cluster binding | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 4 | 21 |
GO:0006468 | protein phosphorylation | 1.31e-02 | 1.00e+00 | 3.435 | 2 | 6 | 301 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 1.41e-02 | 1.00e+00 | 6.145 | 1 | 2 | 23 |
GO:0008180 | COP9 signalosome | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 6 | 24 |
GO:0006370 | 7-methylguanosine mRNA capping | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 5 | 24 |
GO:0004003 | ATP-dependent DNA helicase activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 3 | 25 |
GO:0006360 | transcription from RNA polymerase I promoter | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 4 | 27 |
GO:0008094 | DNA-dependent ATPase activity | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 6 | 29 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.01e-02 | 1.00e+00 | 3.110 | 2 | 21 | 377 |
GO:0007254 | JNK cascade | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 5 | 35 |
GO:0032508 | DNA duplex unwinding | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 3 | 38 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 6 | 40 |
GO:0007059 | chromosome segregation | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 4 | 50 |
GO:0009791 | post-embryonic development | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 2 | 52 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 8 | 52 |
GO:0006289 | nucleotide-excision repair | 3.21e-02 | 1.00e+00 | 4.941 | 1 | 6 | 53 |
GO:0035264 | multicellular organism growth | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 2 | 54 |
GO:0042826 | histone deacetylase binding | 3.51e-02 | 1.00e+00 | 4.810 | 1 | 5 | 58 |
GO:0006979 | response to oxidative stress | 3.87e-02 | 1.00e+00 | 4.668 | 1 | 3 | 64 |
GO:0047485 | protein N-terminus binding | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 6 | 65 |
GO:0030308 | negative regulation of cell growth | 4.23e-02 | 1.00e+00 | 4.539 | 1 | 3 | 70 |
GO:0001649 | osteoblast differentiation | 4.46e-02 | 1.00e+00 | 4.459 | 1 | 5 | 74 |
GO:0005819 | spindle | 4.82e-02 | 1.00e+00 | 4.347 | 1 | 6 | 80 |
GO:0016055 | Wnt signaling pathway | 5.23e-02 | 1.00e+00 | 4.225 | 1 | 6 | 87 |
GO:0005739 | mitochondrion | 5.69e-02 | 1.00e+00 | 2.304 | 2 | 32 | 659 |
GO:0007568 | aging | 5.82e-02 | 1.00e+00 | 4.069 | 1 | 3 | 97 |
GO:0042981 | regulation of apoptotic process | 6.69e-02 | 1.00e+00 | 3.861 | 1 | 4 | 112 |
GO:0008022 | protein C-terminus binding | 6.86e-02 | 1.00e+00 | 3.823 | 1 | 5 | 115 |
GO:0007049 | cell cycle | 6.86e-02 | 1.00e+00 | 3.823 | 1 | 8 | 115 |
GO:0001666 | response to hypoxia | 6.92e-02 | 1.00e+00 | 3.810 | 1 | 2 | 116 |
GO:0004672 | protein kinase activity | 7.44e-02 | 1.00e+00 | 3.703 | 1 | 5 | 125 |
GO:0019904 | protein domain specific binding | 7.73e-02 | 1.00e+00 | 3.646 | 1 | 4 | 130 |
GO:0044212 | transcription regulatory region DNA binding | 8.47e-02 | 1.00e+00 | 3.509 | 1 | 13 | 143 |
GO:0001701 | in utero embryonic development | 9.10e-02 | 1.00e+00 | 3.402 | 1 | 7 | 154 |
GO:0005654 | nucleoplasm | 9.46e-02 | 1.00e+00 | 1.894 | 2 | 68 | 876 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 9.50e-02 | 1.00e+00 | 3.338 | 1 | 18 | 161 |
GO:0005634 | nucleus | 9.92e-02 | 1.00e+00 | 1.004 | 4 | 158 | 3246 |
GO:0005102 | receptor binding | 1.02e-01 | 1.00e+00 | 3.225 | 1 | 3 | 174 |
GO:0046872 | metal ion binding | 1.06e-01 | 1.00e+00 | 1.801 | 2 | 24 | 934 |
GO:0005743 | mitochondrial inner membrane | 1.15e-01 | 1.00e+00 | 3.046 | 1 | 9 | 197 |
GO:0004674 | protein serine/threonine kinase activity | 1.15e-01 | 1.00e+00 | 3.046 | 1 | 8 | 197 |
GO:0005525 | GTP binding | 1.15e-01 | 1.00e+00 | 3.046 | 1 | 12 | 197 |
GO:0006281 | DNA repair | 1.18e-01 | 1.00e+00 | 3.003 | 1 | 24 | 203 |
GO:0008134 | transcription factor binding | 1.22e-01 | 1.00e+00 | 2.961 | 1 | 10 | 209 |
GO:0019899 | enzyme binding | 1.22e-01 | 1.00e+00 | 2.954 | 1 | 7 | 210 |
GO:0006200 | ATP catabolic process | 1.27e-01 | 1.00e+00 | 2.894 | 1 | 13 | 219 |
GO:0030198 | extracellular matrix organization | 1.28e-01 | 1.00e+00 | 2.881 | 1 | 7 | 221 |
GO:0007411 | axon guidance | 1.37e-01 | 1.00e+00 | 2.780 | 1 | 8 | 237 |
GO:0008283 | cell proliferation | 1.38e-01 | 1.00e+00 | 2.768 | 1 | 8 | 239 |
GO:0016020 | membrane | 1.63e-01 | 1.00e+00 | 1.431 | 2 | 56 | 1207 |
GO:0000278 | mitotic cell cycle | 1.78e-01 | 1.00e+00 | 2.374 | 1 | 28 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.80e-01 | 1.00e+00 | 2.360 | 1 | 17 | 317 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.92e-01 | 1.00e+00 | 2.255 | 1 | 23 | 341 |
GO:0042802 | identical protein binding | 1.99e-01 | 1.00e+00 | 2.201 | 1 | 15 | 354 |
GO:0005515 | protein binding | 2.11e-01 | 1.00e+00 | 0.659 | 4 | 198 | 4124 |
GO:0006915 | apoptotic process | 2.27e-01 | 1.00e+00 | 1.985 | 1 | 15 | 411 |
GO:0016032 | viral process | 2.36e-01 | 1.00e+00 | 1.927 | 1 | 30 | 428 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.49e-01 | 1.00e+00 | 1.836 | 1 | 29 | 456 |
GO:0070062 | extracellular vesicular exosome | 2.67e-01 | 1.00e+00 | 0.988 | 2 | 51 | 1641 |
GO:0010467 | gene expression | 2.87e-01 | 1.00e+00 | 1.605 | 1 | 49 | 535 |
GO:0005887 | integral component of plasma membrane | 3.05e-01 | 1.00e+00 | 1.501 | 1 | 8 | 575 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.36e-01 | 1.00e+00 | 1.338 | 1 | 29 | 644 |
GO:0006355 | regulation of transcription, DNA-templated | 3.66e-01 | 1.00e+00 | 1.187 | 1 | 31 | 715 |
GO:0044281 | small molecule metabolic process | 4.19e-01 | 1.00e+00 | 0.947 | 1 | 35 | 844 |
GO:0005524 | ATP binding | 4.37e-01 | 1.00e+00 | 0.868 | 1 | 37 | 892 |
GO:0003677 | DNA binding | 4.58e-01 | 1.00e+00 | 0.781 | 1 | 52 | 947 |
GO:0005886 | plasma membrane | 7.02e-01 | 1.00e+00 | -0.132 | 1 | 46 | 1784 |
GO:0005829 | cytosol | 7.03e-01 | 1.00e+00 | -0.135 | 1 | 88 | 1787 |